The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited-Reference-Cited by-同舟云学术

The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited

Published:2021-11 Issue:5 Volume:80 Page:632-640
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Deek Matthew P.,Van der Eecken Kim,Phillips Ryan,Parikh Neil R.,Isaacsson Velho Pedro,Lotan Tamara L.,Kishan Amar U.,Maurer Tobias,Boutros Paul C.,Hovens Christopher,Abramowtiz Matthew,Pollack Alan,Desai Neil,Stish Bradley,Feng Felix Y.,Eisenberger Mario,Carducci Michael,Pienta Kenneth J.,Markowski Mark,Paller Channing J.,Antonarakis Emmanuel S.,Berlin Alejandro,Ost Piet,Tran Phuoc T.^ORCID

Funder

Movember Foundation

Prostate Cancer Foundation

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. Oligometastases;Hellman;J Clin Oncol,1995

2. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis;Pitroda;Nat Commun,2018

3. microRNAs and oligometastasis;Khodarev;Aging,2015

4. 14q32-encoded microRNAs mediate an oligometastatic phenotype;Uppal;Oncotarget,2015

5. Resection of hepatic metastases from colorectal cancer;Adson;Arch Surg,1984

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OligoM-Cancer: A multidimensional information platform for deep phenotyping of heterogenous oligometastatic cancer;Computational and Structural Biotechnology Journal;2024-12

2. UQCRB and LBH are correlated with Gleason score progression in prostate cancer: Spatial transcriptomics and experimental validation;Computational and Structural Biotechnology Journal;2024-12

3. Prognostic value of circulating tumor cells in oligorecurrent hormone‐sensitive prostate cancer patients undergoing stereotactic body radiation therapy;The Prostate;2024-09-06

4. Metastatic hormone-naïve prostate cancer: a distinct biological entity;Trends in Cancer;2024-09

5. PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer;The Prostate;2024-07-17